Iron transport in a lymphoid cell line with the hemochromatosis C282Y mutation

被引:14
作者
Chitambar, CR [1 ]
Wereley, JP [1 ]
机构
[1] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA
关键词
D O I
10.1182/blood.V97.9.2734
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The gene for hemochromatosis (HFE) is expressed in a variety of cells, including those not thought to be affected by this disease. The impact of HFE on iron transport was examined in B-lymphoid cell lines developed from a patient with hemochromatosis with the HFE C282Y mutation (C282Y cells) and an individual with the wild-type HFE gene (WT cells). Whereas both cell lines expressed HFE protein, C282Y cells displayed less HFE protein at the cell surface. Transferrin receptor (TfR) number was 2- to a-fold greater in WT cells than in C282Y cells, while TfR affinity for transferrin (Tf) was slightly lower in C282Y cells. TfR distribution between intracellular and cell-surface compartments was similar in both cell lines. Iron uptake per cell was greater in WT cells but was not increased proportional to TfR number. When considered relative to cell-surface TfR number, however, iron up take and Tf internalization were actually greater in C282Y cells. Surprisingly, Tf-independent iron uptake was also significantly greater in C282Y cells than in WI cells. The ferritin content of C282Y cells was approximately 40% that of WT cells. Exposure of cells to pro-oxidant conditions in culture led to a greater inhibition of proliferation in C282Y cells than in WT cells. Our results indicate that in this B-lymphoid cell line, the HFE C282Y mutation affects both Tf-dependent and -independent iron uptake and enhances cell sensitivity to oxidative stress. The role of HFE in iron uptake by B cells may extend beyond its known interaction with the TfR. (Blood, 2001;97:2734-2740) (C) 2001 by The American Society of Hematology.
引用
收藏
页码:2734 / 2740
页数:7
相关论文
共 44 条
[21]   Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis [J].
Jeffrey, GP ;
Chakrabarti, S ;
Hegele, RA ;
Adams, PC .
NATURE GENETICS, 1999, 22 (04) :325-326
[22]   A candidate gene for hemochromatosis: frequency of the C282Y and H63D mutations [J].
Jouanolle, AM ;
Fergelot, P ;
Gandon, G ;
Yaouanq, J ;
LeGall, JY ;
David, V .
HUMAN GENETICS, 1997, 100 (5-6) :544-547
[23]  
KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715
[24]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[25]   MODULATION OF CELL-SURFACE IRON TRANSFERRIN RECEPTORS BY CELLULAR DENSITY AND STATE OF ACTIVATION [J].
LARRICK, JW ;
CRESSWELL, P .
JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1979, 11 (04) :579-586
[26]   The C282Y mutation causing hereditary hemochromatosis does not produce a null allele [J].
Levy, JE ;
Montross, LK ;
Cohen, DE ;
Fleming, MD ;
Andrews, NC .
BLOOD, 1999, 94 (01) :9-11
[27]   Elevated ferritin production, iron containment, and oxidant resistance in hemin-treated leukemia cells [J].
Lin, FB ;
Girotti, AW .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 346 (01) :131-141
[28]   Global prevalence of putative haemochromatosis mutations [J].
MerryweatherClarke, AT ;
Pointon, JJ ;
Shearman, JD ;
Robson, KJH .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (04) :275-278
[29]   The haemochromatosis gene: A global perspective and implications for the Asia-Pacific region [J].
Mortimore, M ;
Merryweather-Clarke, AT ;
Robson, KJH ;
Powell, LW .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 14 (09) :838-843